These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 27821382

  • 1. A Prospective, Multicenter, Randomized Phase II Study to Evaluate the Efficacy and Safety of Eculizumab in Patients with Guillain-Barré Syndrome (GBS): Protocol of Japanese Eculizumab Trial for GBS (JET-GBS).
    Yamaguchi N, Misawa S, Sato Y, Nagashima K, Katayama K, Sekiguchi Y, Iwai Y, Amino H, Suichi T, Yokota T, Nishida Y, Kohara N, Hirata K, Nishiyama K, Yabe I, Kaida KI, Suzuki N, Nodera H, Tsuji S, Koike H, Kira JI, Hanaoka H, Kusunoki S, Kuwabara S, JET-GBS GroupDepartment of Neurology and Neurological Science, Tokyo Medical and Dental University, Tokyo, Japan.Department of Neurology, Kobe City Medical Centre General Hospital, Kobe, Japan.Department of Neurology, Dokkyo Medical University, Tochigi, Japan.Department of Neurology, Kitasato University School of Medicine, Kanagawa, Japan.Department of Neurology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.Division of Neurology, Department of Internal Medicine, National Defense Medical College, Saitama, Japan.Department of Neurology, Keio University School of Medicine, Tokyo, Japan.Department of Clinical Neuroscience, Graduate School of Medical Sciences, Tokushima University, Tokushima, Japan.Department of Neurology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.Department of Neurology, Faculty of Medicine, Kindai University, Osaka-Sayama, Japan..
    JMIR Res Protoc; 2016 Nov 07; 5(4):e210. PubMed ID: 27821382
    [Abstract] [Full Text] [Related]

  • 2. Safety and efficacy of eculizumab in Guillain-Barré syndrome: a multicentre, double-blind, randomised phase 2 trial.
    Misawa S, Kuwabara S, Sato Y, Yamaguchi N, Nagashima K, Katayama K, Sekiguchi Y, Iwai Y, Amino H, Suichi T, Yokota T, Nishida Y, Kanouchi T, Kohara N, Kawamoto M, Ishii J, Kuwahara M, Suzuki H, Hirata K, Kokubun N, Masuda R, Kaneko J, Yabe I, Sasaki H, Kaida KI, Takazaki H, Suzuki N, Suzuki S, Nodera H, Matsui N, Tsuji S, Koike H, Yamasaki R, Kusunoki S, Japanese Eculizumab Trial for GBS (JET-GBS) Study Group.
    Lancet Neurol; 2018 Jun 07; 17(6):519-529. PubMed ID: 29685815
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological treatment other than corticosteroids, intravenous immunoglobulin and plasma exchange for Guillain-Barré syndrome.
    Doets AY, Hughes RA, Brassington R, Hadden RD, Pritchard J.
    Cochrane Database Syst Rev; 2020 Jan 25; 1(1):CD008630. PubMed ID: 31981368
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of complement in Guillain-Barré syndrome: the ICA-GBS study.
    Davidson AI, Halstead SK, Goodfellow JA, Chavada G, Mallik A, Overell J, Lunn MP, McConnachie A, van Doorn P, Willison HJ.
    J Peripher Nerv Syst; 2017 Mar 25; 22(1):4-12. PubMed ID: 27801990
    [Abstract] [Full Text] [Related]

  • 5. The Japanese Early-Stage Trial of High-Dose Methylcobalamin for Amyotrophic Lateral Sclerosis (JETALS): Protocol for a Randomized Controlled Trial.
    Oki R, Izumi Y, Nodera H, Sato Y, Nokihara H, Kanai K, Sonoo M, Urushitani M, Nishinaka K, Atsuta N, Kohara N, Shimizu T, Kikuchi H, Oda M, Ikeda K, Nagai M, Komai K, Kojima Y, Kuzume D, Isose S, Shimohama S, Abe K, Ito H, Noda K, Ishihara T, Morita M, Shimohata T, Teramukai S, Kagimura T, Noma K, Yanagawa H, Kuwabara S, Kaji R, JETALS.
    JMIR Res Protoc; 2018 Dec 21; 7(12):e12046. PubMed ID: 30578206
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pharmacological treatment for pain in Guillain-Barré syndrome.
    Liu J, Wang LN, McNicol ED.
    Cochrane Database Syst Rev; 2013 Oct 20; (10):CD009950. PubMed ID: 24142399
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Second IVIg course in Guillain-Barré syndrome patients with poor prognosis (SID-GBS trial): Protocol for a double-blind randomized, placebo-controlled clinical trial.
    Walgaard C, Jacobs BC, Lingsma HF, Steyerberg EW, Cornblath DR, van Doorn PA, Dutch GBS Study Group.
    J Peripher Nerv Syst; 2018 Dec 20; 23(4):210-215. PubMed ID: 30151941
    [Abstract] [Full Text] [Related]

  • 13. [Complement-Mediated Mechanism and Complement Inhibitors in Guillain-Barré Syndrome].
    Kuwahara M, Kusunoki S.
    Brain Nerve; 2019 Jun 20; 71(6):581-587. PubMed ID: 31171755
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effectiveness of web-based self-disclosure peer-to-peer support for weight loss: randomized controlled trial.
    Imanaka M, Ando M, Kitamura T, Kawamura T.
    J Med Internet Res; 2013 Jul 09; 15(7):e136. PubMed ID: 23838533
    [Abstract] [Full Text] [Related]

  • 18. Study protocol for daiobotanpito combined with antibiotic therapy for treatment of acute diverticulitis: a study protocol for a randomized controlled trial.
    Ogawa-Ochiai K, Yoshimura K, Shirai A, Sakai S, Moriyama H, Nakamura K, Murayama T, Ishikawa H.
    Trials; 2020 Jun 16; 21(1):531. PubMed ID: 32546262
    [Abstract] [Full Text] [Related]

  • 19. Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial.
    Walgaard C, Jacobs BC, Lingsma HF, Steyerberg EW, van den Berg B, Doets AY, Leonhard SE, Verboon C, Huizinga R, Drenthen J, Arends S, Budde IK, Kleyweg RP, Kuitwaard K, van der Meulen MFG, Samijn JPA, Vermeij FH, Kuks JBM, van Dijk GW, Wirtz PW, Eftimov F, van der Kooi AJ, Garssen MPJ, Gijsbers CJ, de Rijk MC, Visser LH, Blom RJ, Linssen WHJP, van der Kooi EL, Verschuuren JJGM, van Koningsveld R, Dieks RJG, Gilhuis HJ, Jellema K, van der Ree TC, Bienfait HME, Faber CG, Lovenich H, van Engelen BGM, Groen RJ, Merkies ISJ, van Oosten BW, van der Pol WL, van der Meulen WDM, Badrising UA, Stevens M, Breukelman AJ, Zwetsloot CP, van der Graaff MM, Wohlgemuth M, Hughes RAC, Cornblath DR, van Doorn PA, Dutch GBS Study Group.
    Lancet Neurol; 2021 Apr 16; 20(4):275-283. PubMed ID: 33743237
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of Mobile Serious Games in Increasing HIV Risk Perception in Swaziland: A Randomized Control Trial (SGprev Trial) Research Protocol.
    Lukhele BW, Musumari P, El-Saaidi C, Techasrivichien T, Suguimoto SP, Ono Kihara M, Kihara M.
    JMIR Res Protoc; 2016 Nov 22; 5(4):e224. PubMed ID: 27876685
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.